Sanofi ADR EBITDA vs. Number of Employees

SNY Stock  USD 48.40  1.14  2.30%   
Considering Sanofi ADR's profitability and operating efficiency indicators, Sanofi ADR is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in April. Profitability indicators assess Sanofi ADR's ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
13 B
Current Value
9.8 B
Quarterly Volatility
2.8 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Sanofi ADR's Price To Sales Ratio is fairly stable compared to the past year. Operating Cash Flow Sales Ratio is likely to rise to 0.26 in 2024, whereas Days Of Sales Outstanding is likely to drop 86.44 in 2024. At this time, Sanofi ADR's Net Income From Continuing Ops is fairly stable compared to the past year. Interest Income is likely to rise to about 573.3 M in 2024, whereas Accumulated Other Comprehensive Income is likely to drop slightly above 4.6 B in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.790.6152
Significantly Up
Very volatile
Net Profit Margin0.120.1254
Sufficiently Down
Pretty Stable
Operating Profit Margin0.220.2132
Sufficiently Up
Pretty Stable
Pretax Profit Margin0.210.1661
Significantly Up
Pretty Stable
Return On Assets0.07730.0427
Way Up
Very volatile
Return On Equity0.130.0729
Way Up
Very volatile
For Sanofi ADR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sanofi ADR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sanofi ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sanofi ADR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sanofi ADR over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.217
Dividend Share
3.76
Earnings Share
2.33
Revenue Per Share
18.388
Quarterly Revenue Growth
0.029
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sanofi ADR Number of Employees vs. EBITDA Fundamental Analysis

Sanofi Number of Employees vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Sanofi ADR

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
12.96 B
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Sanofi ADR

 = 
null

Use Sanofi ADR in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sanofi ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi ADR will appreciate offsetting losses from the drop in the long position's value.

Sanofi ADR Pair Trading

Sanofi ADR Pair Trading Analysis

The ability to find closely correlated positions to Sanofi ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sanofi ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sanofi ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sanofi ADR to buy it.
The correlation of Sanofi ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sanofi ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sanofi ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sanofi ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sanofi ADR position

In addition to having Sanofi ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Advertising Thematic Idea Now

Advertising
Advertising Theme
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:
Check out World Market Map.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Sanofi Stock analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
To fully project Sanofi ADR's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sanofi ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sanofi ADR's income statement, its balance sheet, and the statement of cash flows.
Potential Sanofi ADR investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Sanofi ADR investors may work on each financial statement separately, they are all related. The changes in Sanofi ADR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sanofi ADR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.